CareDx Reports Strong Q1, Acquires Naveris, Launches $100M Buyback, and Resolves DOJ Qui Tam Action

summarizeSummary

CareDx reported strong Q1 results, announced a strategic acquisition of Naveris for up to $260M, authorized a new $100M share repurchase program, and disclosed the resolution of a long-standing DOJ qui tam action.

check_boxKey Events

• Strong First Quarter Financial Performance

  CareDx reported total revenue of $117.7 million for Q1 2026, a 39% increase year-over-year, and achieved a net income of $2.8 million, a significant turnaround from a net loss of $10.3 million in Q1 2025. Cash flow from operations also turned positive at $4.3 million, compared to a negative $26.6 million in the prior year period.

• Strategic Acquisition of Naveris, Inc.

  The company entered into an agreement on April 28, 2026, to acquire Naveris, Inc. for an aggregate of $160 million in cash upfront, with potential for up to an additional $100 million in contingent cash consideration based on revenue milestones for fiscal years 2026 and 2027. This acquisition represents a substantial strategic expansion.

• New $100 Million Share Repurchase Program Authorized

  On April 24, 2026, the Board of Directors authorized a new share repurchase program of up to $100 million over a two-year period, commencing April 30, 2026. This follows the May 2025 program, which had $12.2 million remaining as of March 31, 2026.

• Resolution of DOJ Qui Tam Action

  On April 23, 2026, the private plaintiff in the qui tam action, which served as the basis for the Department of Justice investigation, filed a notice of voluntary dismissal of the case, with the DOJ consenting to the dismissal. This resolves a significant legal overhang for the company.

auto_awesomeAnalysis

CareDx, Inc. delivered a strong first quarter, significantly exceeding prior year performance by swinging to profitability and generating positive operating cash flow. Beyond the robust financial results, the filing discloses several highly material subsequent events. The acquisition of Naveris for up to $260 million (including contingent consideration) marks a substantial strategic expansion, while the authorization of a new $100 million share repurchase program signals strong management confidence and a commitment to shareholder value. Critically, the voluntary dismissal of the Department of Justice qui tam action removes a significant legal and regulatory overhang that has impacted the company for years, de-risking its operational environment. These combined developments present a very positive outlook for the company.